#SFHS2608457VNotice on Prices of Pharmaceutical Specialties Published Pursuant to Article L. 162-16-5 of the Social Security Code
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This official French notice sets the ex-tax selling price for a generic posaconazole tablet produced by Arrow Generiques. Under an agreement with the Economic Committee for Health Products (CEPS) and Article L. 162-16-5 of the Social Security Code, the price for hospitals and healthcare establishments is fixed at 10.427 euros per unit (UCD code 3400890052412). Both the selling price excluding tax and the unified tariff are identical at €10.427 per UCD. The medicine is 100mg posaconazole film-coated tablets. This price publication enables hospitals to purchase the antifungal medication at the regulated rate.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Sets hospital selling price (HT) for Arrow Generiques Posaconazole 100mg tablets at exactly 10.427 € per UCD
- Applies unified tariff of 10.427 € identical to the selling price
- Concerns UCD code 3400890052412 for posaconazole 100 mg film-coated tablets
+ 3 more changes with Pro
Obligations
What this law requires
Set and maintain the ex-tax selling price for posaconazole 100mg film-coated tablets (UCD code 3400890052412) at €10.427 per unit for healthcare establishments
Ensure the unified tariff for posaconazole 100mg tablets matches the ex-tax selling price at €10.427 per UCD
Publish and disclose the regulated price of €10.427 per unit to healthcare establishments and relevant authorities in accordance with Article L. 162-16-5 of the Social Security Code
Apply prices only through the convention agreement established with the Economic Committee for Health Products (CEPS)
Maintain compliance with Article L. 162-16-5 of the Social Security Code regarding pharmaceutical price regulation and publication requirements